Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer. Shitara K, Bang YJ, Iwasa S, Sugimoto N, et al. N Engl J Med 2020 May 29. doi: 10.1056/NEJMoa2004413.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shitara K, Bang YJ, Iwasa S, Sugimoto N, et al. Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer. N Engl J Med 2020 May 29. doi: 10.1056/NEJMoa2004413.
PMID: 32469182